Skip to main content
Top
Published in: Journal of Hematology & Oncology 1/2010

Open Access 01-12-2010 | Research

Autoimmune conditions and hairy cell leukemia: an exploratory case-control study

Authors: Lesley A Anderson, Eric A Engels

Published in: Journal of Hematology & Oncology | Issue 1/2010

Login to get access

Abstract

Background

Case reports suggest that hairy cell leukemia (HCL) may be associated with autoimmune conditions, however no systematic investigations in this area have been undertaken.

Methods

Using the United States Surveillance, Epidemiology, and End Results Medicare linked database, we conducted an exploratory study comparing autoimmune conditions in 418 HCL cases (aged ≥65 years) and 160,086 controls.

Results

Overall, the proportion with autoimmune conditions was similar between HCL cases and controls (n = 79 (18.9%) and n = 29,284 (18.3%), respectively). Before diagnosis/selection, there was no overall difference in the prevalence of autoimmune conditions in HCL cases (n = 37, 8.9%) compared with controls (n = 14,085, 8.8%), p = 0.969. However, compared with controls, HCL cases more frequently had sarcoidosis (OR 9.6, 95%CI 2.4-39.5), Sjögren syndrome (OR 6.1, 95%CI 2.0-19.3) and erythema nodosum (OR 37, 95%CI 4.9-284) before diagnosis. Autoimmune conditions were also more common in HCL cases than controls around the time of diagnosis/selection (p < 0.001) but not subsequently.

Conclusions

The findings do not support an overall relationship between autoimmune conditions and HCL, although the association with some autoimmune conditions prior to HCL diagnosis may warrant further investigation. Our findings also suggest that autoimmune conditions in HCL patients may be detected around the time of diagnosis.
Literature
1.
go back to reference Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS: Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006, 107: 265-276. 10.1182/blood-2005-06-2508.PubMedCentralCrossRefPubMed Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS: Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006, 107: 265-276. 10.1182/blood-2005-06-2508.PubMedCentralCrossRefPubMed
2.
go back to reference Oleske D, Golomb HM, Farber MD, Levy PS: A case-control inquiry into the etiology of hairy cell leukemia. Am J Epidemiol. 1985, 121: 675-683. 10.1093/aje/121.5.675.CrossRefPubMed Oleske D, Golomb HM, Farber MD, Levy PS: A case-control inquiry into the etiology of hairy cell leukemia. Am J Epidemiol. 1985, 121: 675-683. 10.1093/aje/121.5.675.CrossRefPubMed
3.
go back to reference Ekstrom SK, Vajdic CM, Falster M, Engels EA, Martinez-Maza O, Turner J, Hjalgrim H, Vineis P, Seniori Costantini A, Bracci PM, Holly EA, Willett E, Spinelli JJ, La Vecchia C, Zheng T, Becker N, De Sanjosé S, Chiu BC, Dal Maso L, Cocco P, Maynadié M, Foretova L, Staines A, Brennan P, Davis S, Severson R, Cerhan JR, Breen EC, Birmann B, Grulich AE, Cozen W: Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood. 2008, 111: 4029-4038. 10.1182/blood-2007-10-119974.CrossRef Ekstrom SK, Vajdic CM, Falster M, Engels EA, Martinez-Maza O, Turner J, Hjalgrim H, Vineis P, Seniori Costantini A, Bracci PM, Holly EA, Willett E, Spinelli JJ, La Vecchia C, Zheng T, Becker N, De Sanjosé S, Chiu BC, Dal Maso L, Cocco P, Maynadié M, Foretova L, Staines A, Brennan P, Davis S, Severson R, Cerhan JR, Breen EC, Birmann B, Grulich AE, Cozen W: Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood. 2008, 111: 4029-4038. 10.1182/blood-2007-10-119974.CrossRef
4.
go back to reference Fozza C, Dore F, Bonfigli S, Podda L, Longinotti M: Two cases of chronic lymphoproliferative disorders in psoriatic patients treated with cyclosporine: hairy cell leukemia and Waldenstrom macroglobulinemia. Eur J Dermatol. 2005, 15: 271-273.PubMed Fozza C, Dore F, Bonfigli S, Podda L, Longinotti M: Two cases of chronic lymphoproliferative disorders in psoriatic patients treated with cyclosporine: hairy cell leukemia and Waldenstrom macroglobulinemia. Eur J Dermatol. 2005, 15: 271-273.PubMed
5.
go back to reference Goedert JJ, Neefe JR, Smith FS, Stahl NI, Jaffe ES, Fauci AS: Polyarteritis nodosa, hairy cell leukemia and splenosis. Am J Med. 1981, 71: 323-326. 10.1016/0002-9343(81)90136-4.CrossRefPubMed Goedert JJ, Neefe JR, Smith FS, Stahl NI, Jaffe ES, Fauci AS: Polyarteritis nodosa, hairy cell leukemia and splenosis. Am J Med. 1981, 71: 323-326. 10.1016/0002-9343(81)90136-4.CrossRefPubMed
6.
go back to reference Krause JR: Aplastic anemia terminating in hairy cell leukemia. A report of two cases. Cancer. 1984, 53: 1533-1537. 10.1002/1097-0142(19840401)53:7<1533::AID-CNCR2820530719>3.0.CO;2-7.CrossRefPubMed Krause JR: Aplastic anemia terminating in hairy cell leukemia. A report of two cases. Cancer. 1984, 53: 1533-1537. 10.1002/1097-0142(19840401)53:7<1533::AID-CNCR2820530719>3.0.CO;2-7.CrossRefPubMed
7.
go back to reference Manna R, Perri F, Ghirlanda G, Zeppilli P, Carughi S, Annese V, Uccioli L, Mango G: Association of ankylosing spondylitis with hairy cell leukemia: a previously once reported case. Z Rheumatol. 1985, 44: 93-96.PubMed Manna R, Perri F, Ghirlanda G, Zeppilli P, Carughi S, Annese V, Uccioli L, Mango G: Association of ankylosing spondylitis with hairy cell leukemia: a previously once reported case. Z Rheumatol. 1985, 44: 93-96.PubMed
8.
go back to reference Schiller G, Said J, Pal S: Hairy cell leukemia and sarcoidosis: a case report and review of the literature. Leukemia. 2003, 17: 2057-2059. 10.1038/sj.leu.2403074.CrossRefPubMed Schiller G, Said J, Pal S: Hairy cell leukemia and sarcoidosis: a case report and review of the literature. Leukemia. 2003, 17: 2057-2059. 10.1038/sj.leu.2403074.CrossRefPubMed
9.
go back to reference Anderson LA, Pfeiffer R, Warren JL, Landgren O, Gadalla S, Berndt SI, Ricker W, Parsons R, Wheeler W, Engels EA: Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomarkers Prev. 2008, 17: 3069-3075. 10.1158/1055-9965.EPI-08-0408.PubMedCentralCrossRefPubMed Anderson LA, Pfeiffer R, Warren JL, Landgren O, Gadalla S, Berndt SI, Ricker W, Parsons R, Wheeler W, Engels EA: Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomarkers Prev. 2008, 17: 3069-3075. 10.1158/1055-9965.EPI-08-0408.PubMedCentralCrossRefPubMed
10.
go back to reference Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF: Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002, 40: IV-18. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF: Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002, 40: IV-18.
11.
go back to reference Ramos-Casals M, Brito-Zeron P, Font J: The Overlap of Sjögren's syndrome with other systemic autoimmune diseases. Sem Arthritis Rheumatism. 2007, 36 (4): 246-255. 10.1016/j.semarthrit.2006.08.007.CrossRef Ramos-Casals M, Brito-Zeron P, Font J: The Overlap of Sjögren's syndrome with other systemic autoimmune diseases. Sem Arthritis Rheumatism. 2007, 36 (4): 246-255. 10.1016/j.semarthrit.2006.08.007.CrossRef
12.
go back to reference Patel RR, Kirland EB, Nquyen DH, Cooper BW, Baron ED, Gilliam AC: Erythema nodosum in association with newly diagnosed hairy cell leukemia and group C streptococcus infection. Am J Dermatopathol. 2008, 30 (2): 160-2. 10.1097/DAD.0b013e3181618a8a.CrossRefPubMed Patel RR, Kirland EB, Nquyen DH, Cooper BW, Baron ED, Gilliam AC: Erythema nodosum in association with newly diagnosed hairy cell leukemia and group C streptococcus infection. Am J Dermatopathol. 2008, 30 (2): 160-2. 10.1097/DAD.0b013e3181618a8a.CrossRefPubMed
13.
go back to reference Hjelmstrom P. Lymphoid: neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J Leukoc Biol. 2001, 69: 331-339.PubMed Hjelmstrom P. Lymphoid: neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J Leukoc Biol. 2001, 69: 331-339.PubMed
14.
go back to reference Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, Catrina AI, Rosenquist R, Feltelius N, Sundström C, Klareskog L: Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum. 2006, 54 (3): 692-701. 10.1002/art.21675.CrossRefPubMed Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, Catrina AI, Rosenquist R, Feltelius N, Sundström C, Klareskog L: Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum. 2006, 54 (3): 692-701. 10.1002/art.21675.CrossRefPubMed
15.
go back to reference Dores GM, Matsuno RK, Weisenburger DD, Rosenberg PS, Anderson WF: Hairy cell leukemia: a heterogeneous disease?. Br J Haematol. 2008, 142 (1): 45-51. 10.1111/j.1365-2141.2008.07156.x.PubMedCentralCrossRefPubMed Dores GM, Matsuno RK, Weisenburger DD, Rosenberg PS, Anderson WF: Hairy cell leukemia: a heterogeneous disease?. Br J Haematol. 2008, 142 (1): 45-51. 10.1111/j.1365-2141.2008.07156.x.PubMedCentralCrossRefPubMed
Metadata
Title
Autoimmune conditions and hairy cell leukemia: an exploratory case-control study
Authors
Lesley A Anderson
Eric A Engels
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of Hematology & Oncology / Issue 1/2010
Electronic ISSN: 1756-8722
DOI
https://doi.org/10.1186/1756-8722-3-35

Other articles of this Issue 1/2010

Journal of Hematology & Oncology 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine